Latest filing published 24 Feb 2026 for Vicarious Surgical Inc., €1,671. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Adam David Sachs, listed as chief executive, appears in our data through filings on Vicarious Surgical Inc. shares, published by SEC (Form 4). Over a trading history stretching from 17 September 2021 to 20 February 2026, the count stands at 54 filings.
No open-market purchase appears, only 40 sales worth €478k. Other entries cover 6 share grants. 2026 to date brings no purchases and 1 sale.
The latest filing, published on 24 February 2026, reports an open-market sale of €1,671 in Vicarious Surgical Inc. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 54 declarations